Anterix (ATEX) EBT (2013 - 2025)

Anterix has reported EBT for 13 years, with the latest figure at -$8.7 million in Q4 2025.

• For the quarter ending Q4 2025, EBT fell 215.74% year-over-year to -$8.7 million; the trailing twelve-month figure through Dec 2025 stood at $85.2 million (up 394.8% YoY), and the FY2025 full-year result was -$9.5 million, down 26.15% from the prior year.
• EBT for Q4 2025 stood at -$8.7 million, down from $61.1 million in the prior quarter.
• The five-year high for EBT was $61.1 million in Q3 2025, with the low at -$14.3 million in Q2 2024.
• Historically, EBT has averaged -$219200.0 across 5 years, with a median of -$8.2 million in 2022.
• Annual changes were most pronounced in 2024 — EBT sank 561.22% — and 2025, when it soared 587.03%.
• Anterix's EBT stood at -$12.3 million in 2021, then jumped by 36.52% to -$7.8 million in 2022, then jumped by 121.33% to $1.7 million in 2023, then surged by 348.74% to $7.5 million in 2024, then tumbled by 215.74% to -$8.7 million in 2025.
• The last three EBT figures came in at -$8.7 million (Q4 2025), $61.1 million (Q3 2025), and $22.9 million (Q2 2025), per Business Quant data.